• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[心血管预防建议。PAPPS 2022主题更新。PAPPS工作组]

[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].

作者信息

Orozco-Beltrán Domingo, Brotons Cuixart Carlos, Banegas Banegas Jose R, Gil Guillén Vicente F, Cebrián Cuenca Ana M, Martín Rioboó Enrique, Jordá Baldó Ariana, Vicuña Johanna, Navarro Pérez Jorge

机构信息

Medicina Familiar y Comunitaria, Unidad de Investigación Centro de Salud Cabo Huertas, Departamento San Juan de Alicante. Departamento de Medicina Clínica, Universidad Miguel Hernández, San Juan de Alicante, España.

Medicina Familiar y Comunitaria. Instituto de Investigación Biomédica (IIB) Sant Pau. Equipo de Atención Primaria Sardenya, Barcelona, España.

出版信息

Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102444. doi: 10.1016/j.aprim.2022.102444.

DOI:10.1016/j.aprim.2022.102444
PMID:36435583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9705225/
Abstract

The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; cardiovascular (CV) risk and recommendations for the calculation of CV risk; main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; indications for antiplatelet therapy, and recommendations for screening of atrial fibrillation, and recommendations for management of chronic conditions. The quality of testing and the strength of the recommendation are included in the main recommendations.

摘要

本文介绍了西班牙基础医学教育与继续医学教育体系（semFYC）预防活动与健康促进项目（PAPPS）针对心血管疾病（CVD）预防的建议。内容包括以下几个部分：流行病学综述，描述了西班牙目前心血管疾病的发病率、死亡率及其演变情况以及主要危险因素；心血管（CV）风险及CV风险计算建议；主要危险因素，如动脉高血压、血脂异常和糖尿病，阐述了其诊断方法、治疗目标以及生活方式措施和药物治疗建议；抗血小板治疗指征、心房颤动筛查建议以及慢性病管理建议。主要建议中包含了检测质量和推荐强度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/bb7e51624a64/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/6e550a8f1d59/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/1ad6449e27bf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/aa4f34a9b005/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/22b9a5e027b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/33df3528bd71/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/bb7e51624a64/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/6e550a8f1d59/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/1ad6449e27bf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/aa4f34a9b005/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/22b9a5e027b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/33df3528bd71/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd01/9705225/bb7e51624a64/gr6.jpg

相似文献

1
[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].[心血管预防建议。PAPPS 2022主题更新。PAPPS工作组]
Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102444. doi: 10.1016/j.aprim.2022.102444.
2
[Cardiovascular preventive recommendations. PAPPS 2020 update].[心血管预防建议。PAPPS 2020更新版]
Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):5-31. doi: 10.1016/j.aprim.2020.08.002.
3
[Analysis of the situation, evaluation and improvement proposals of the Preventive Activities and Health Promotion Program (PAPPS)].[预防活动与健康促进计划（PAPPS）的情况分析、评估及改进建议]
Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):161-172. doi: 10.1016/j.aprim.2020.09.002.
4
[PAPPS expert group. Lifestyle recommendations].[PAPPS专家小组。生活方式建议]
Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):32-43. doi: 10.1016/j.aprim.2020.07.004.
5
[Effectiveness of preventive activities analyzed within the framework of health centers involved in the Program for Preventive Activities and Health Promotion (PAPPS) of the semFYC. Group for the Evaluation of PAPPS].[在参与semFYC预防活动与健康促进计划（PAPPS）的健康中心框架内分析预防活动的有效性。PAPPS评估小组]
Aten Primaria. 2000 Apr 15;25(6):383-9. doi: 10.1016/s0212-6567(00)78527-1.
6
[Opinions of health professionals on the impact of the Preventive Activities and Health Promotion Program (PAPPS)].[卫生专业人员对预防活动与健康促进计划（PAPPS）影响的看法]
Aten Primaria. 2007 Nov;39 Suppl 3:5-14.
7
[PAPPS GdT Major 2020 Update].[PAPPS GdT 2020 重大更新]
Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):114-124. doi: 10.1016/j.aprim.2020.09.005.
8
Guía de práctica clínica mexicana para el diagnóstico y tratamiento de las dislipidemias y enfermedad cardiovascular aterosclerótica.墨西哥血脂异常和动脉粥样硬化性心血管疾病诊断与治疗临床实践指南。
Arch Cardiol Mex. 2022;92(Supl):1-62. doi: 10.24875/ACM.M22000081.
9
[PAPPS expert group: Lifestyle recommendations].[PAPPS专家小组：生活方式建议]
Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102442. doi: 10.1016/j.aprim.2022.102442.
10
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.他汀类药物用于成年人的心血管疾病一级预防：美国预防服务工作组推荐声明。
JAMA. 2022 Aug 23;328(8):746-753. doi: 10.1001/jama.2022.13044.

引用本文的文献

1
Methods and validity indicators for measuring adherence and persistence to aspirin in secondary cardiovascular prevention: a systematic review.二级心血管预防中测量阿司匹林依从性和持续性的方法及有效性指标：一项系统评价
Front Cardiovasc Med. 2025 May 26;12:1570331. doi: 10.3389/fcvm.2025.1570331. eCollection 2025.
2
[Cardiovascular preventive recommendations. PAPPS 2024 thematic updates].[心血管疾病预防建议。PAPPS 2024主题更新]
Aten Primaria. 2024 Nov;56 Suppl 1(Suppl 1):103123. doi: 10.1016/j.aprim.2024.103123.
3
Prostate Cancer and the Mevalonate Pathway.

本文引用的文献

1
Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial.丹麦心血管疾病筛查（DANCAVAS）试验的五年结果。
N Engl J Med. 2022 Oct 13;387(15):1385-1394. doi: 10.1056/NEJMoa2208681. Epub 2022 Aug 27.
2
Characterizing Diagnostic Inertia in Arterial Hypertension With a Gender Perspective in Primary Care.从性别视角在初级保健中对动脉高血压诊断惰性的特征分析
Front Cardiovasc Med. 2022 Jun 16;9:874764. doi: 10.3389/fcvm.2022.874764. eCollection 2022.
3
Effect of Different Glucose Monitoring Methods on Bold Glucose Control: A Systematic Review and Meta-Analysis.
前列腺癌与甲羟戊酸途径。
Int J Mol Sci. 2024 Feb 10;25(4):2152. doi: 10.3390/ijms25042152.
4
[Effectiveness of the clinical assistant in the control of hypertensive and diabetic patients in primary care].[临床助手在基层医疗中对高血压和糖尿病患者的管理效果]
Aten Primaria. 2024 Jun;56(6):102853. doi: 10.1016/j.aprim.2023.102853. Epub 2024 Jan 19.
不同血糖监测方法对血糖控制的影响：系统评价和荟萃分析。
Comput Math Methods Med. 2022 Jun 18;2022:2851572. doi: 10.1155/2022/2851572. eCollection 2022.
4
Prediction of atrial fibrillation in patients with hypertension: A comprehensive comparison of office and ambulatory blood pressure measurements.高血压患者心房颤动的预测：诊室血压测量与动态血压测量的综合比较。
J Clin Hypertens (Greenwich). 2022 Jul;24(7):838-847. doi: 10.1111/jch.14524. Epub 2022 Jun 13.
5
Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies.强化血糖控制与老年（年龄≥60 岁）或虚弱的 2 型糖尿病成人的大血管、微血管、低血糖并发症和死亡率：来自随机对照试验和观察研究的系统评价和荟萃分析。
Expert Rev Endocrinol Metab. 2022 May;17(3):255-267. doi: 10.1080/17446651.2022.2079495. Epub 2022 May 25.
6
Prediabetes and Diabetes Screening Eligibility and Detection in US Adults After Changes to US Preventive Services Task Force and American Diabetes Association Recommendations.美国预防服务工作组和美国糖尿病协会建议修改后，美国成年人的糖尿病前期和糖尿病筛查资格和检测。
JAMA. 2022 May 17;327(19):1924-1925. doi: 10.1001/jama.2022.5185.
7
Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials.胰高血糖素样肽-1（GLP-1）受体激动剂与 2 型糖尿病患者的心血管事件：一项双盲、随机、安慰剂对照临床试验的荟萃分析。
BMC Endocr Disord. 2022 May 12;22(1):125. doi: 10.1186/s12902-022-01036-0.
8
Effectiveness of Strategies for Nutritional Therapy for Patients with Type 2 Diabetes and/or Hypertension in Primary Care: A Systematic Review and Meta-Analysis.营养疗法策略对 2 型糖尿病和/或高血压患者在初级保健中的有效性：系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Apr 2;19(7):4243. doi: 10.3390/ijerph19074243.
9
[Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention].[西班牙跨学科血管预防委员会关于欧洲心血管疾病预防最新指南的声明]
Hipertens Riesgo Vasc. 2022 Apr-Jun;39(2):69-78. doi: 10.1016/j.hipert.2022.02.003. Epub 2022 Mar 21.
10
Barriers and Solutions to Improve Therapeutic Adherence from the Perspective of Primary Care and Hospital-Based Physicians.从基层医疗和医院医生角度看提高治疗依从性的障碍与解决方案
Patient Prefer Adherence. 2022 Mar 11;16:697-707. doi: 10.2147/PPA.S319084. eCollection 2022.